Patents/Assignees

Crossignal Therapeutics, Inc.

1 patent in portfolio

US12065444utility2024
Substituted Tetrazolo[1,5-a]pyrazines and Tetrazolo[1,5-c]pyrimidines as Adenosine Receptor Antagonists
0 cites